Among patients treated with NAC for early-stage BC, residual nodal disease, inflammatory BC, and HER2+ or triple-negative subtype are associated with a higher risk of BrM development and whether BrM screening is warranted among patients with these high-risk features warrants evaluation.
An internally validated prediction model for BrM in GI cancers developed and validated performance in a held-out cohort to develop a clinically interpretable prediction model.
M. V. Barcelona, K. Kataki, F. A. Rahman et al.· British Journal of Cancer· 0 citations
Findings underline the predominance of breast cancer among middle-aged and older women and the value of Ki-67 as a marker of tumour aggressiveness and confirm the prognostic relevance of HR status and emphasise the importance of early detection and personalised follow-up.
Olfa Aissa, Aicha Rabah, A. Bousahba et al.· ecancermedicalscience· 0 citations
The presence of residual nodal disease post-NAC helps distinguish between favorable and unfavorable outcomes in different TNBC subtypes, and underscores the importance of developing more individualized radiotherapy strategies following NAC for each molecular subtype.
S. Shao, Wei Shi, Li Zhang et al.· Frontiers in Oncology· 0 citations
The results show that patients who received chemotherapy demonstrated a shorter median RFS compared to those who did not, and radiotherapy was associated with improved prognosis, in line with meta-analyses showing reduced breast cancer mortality post-radiotherapy.
Boby Al Qurthuby, I. M. Murwantara· International Journal of Adv...· 0 citations
BACKGROUND
The role of liver-directed therapy in breast cancer liver metastases (BCLM) remains controversial, and evidence guiding patient selection is limited. This study aimed to characterize patients undergoing local treatment for BCLM and identify prognostic factors associated with outcomes.
METHODS
In this natio...
L. Mikkelsen, L. R. Jensen, A. Bjerrum et al.· Surgical oncology· 0 citations
Background and objectives: Neoadjuvant chemotherapy has become a commonly used method of treatment for individuals diagnosed with breast cancer. It involves administering it before surgery or radiation therapy, aiming to shrink tumors and possibly enhance surgical results. This study evaluates the impact of Neoadjuvant...
Iman Abdulhakim Dawod Dawod, R. Abduljabbar, R. Othman· Advanced medical journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
